Macclesfield, United Kingdom

Neda Yavari

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2015-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Neda Yavari. Retrieved from https://idiyas.com/inventor/neda-yavari

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Neda Yavari: Innovator in Chemical Compounds

Introduction

Neda Yavari is a prominent inventor based in Macclesfield, GB. She has made significant contributions to the field of chemical compounds, holding a total of 3 patents. Her work focuses on innovative solutions for treating cell proliferative disorders.

Latest Patents

Neda's latest patents involve the development of chemical compounds of Formula (I) or pharmaceutically-acceptable salts thereof. These compounds are designed for processes of preparation, pharmaceutical compositions, and their application in treating various cell proliferative disorders. Her inventions are crucial in advancing medical treatments and improving patient outcomes.

Career Highlights

Neda Yavari is associated with AstraZeneca AB, a leading global biopharmaceutical company. Her role at AstraZeneca allows her to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Some of Neda's notable coworkers include Robert Hugh Bradbury and David Buttar. Their collaborative efforts enhance the innovative environment at AstraZeneca, fostering advancements in pharmaceutical science.

Conclusion

Neda Yavari's contributions to the field of chemical compounds exemplify her dedication to innovation and improving healthcare. Her patents and collaborations reflect her commitment to advancing medical science and addressing critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…